Your browser doesn't support javascript.
loading
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.
Vitale, Giovanni; Caraglia, Michele; Jung, Volker; Kamradt, Jörn; Gentilini, Davide; Di Martino, Maria Teresa; Dicitore, Alessandra; Abate, Marianna; Tagliaferri, Pierosandro; Itro, Annalisa; Ferro, Matteo; Balsamo, Raffaele; De Sio, Marco; Facchini, Gaetano; Persani, Luca; Schmitt, Kai; Saar, Matthias; Stöckle, Michael; Unteregger, Gerhard; Zappavigna, Silvia.
Afiliação
  • Vitale G; Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, 20133 Milan, Italy.
  • Caraglia M; Laboratory of Geriatric and Oncologic Neuroendocrinology Research, Istituto Auxologico Italiano (IRCCS), Cusano Milanino, 20095 Milan, Italy.
  • Jung V; Department of Precision Medicine, University of Campania "L Vanvitelli", 80138 Naples, Italy.
  • Kamradt J; Clinic of Urology and Pediatric Urology, University of Saarland, 66421 Homburg, Germany.
  • Gentilini D; Clinic of Urology and Pediatric Urology, University of Saarland, 66421 Homburg, Germany.
  • Di Martino MT; Bioinformatics and Statistical Genomics Unit, Istituto Auxologico Italiano (IRCCS), 20095 Milan, Italy.
  • Dicitore A; Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.
  • Abate M; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
  • Tagliaferri P; Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, 20133 Milan, Italy.
  • Itro A; Department of Precision Medicine, University of Campania "L Vanvitelli", 80138 Naples, Italy.
  • Ferro M; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
  • Balsamo R; Department of Precision Medicine, University of Campania "L Vanvitelli", 80138 Naples, Italy.
  • De Sio M; Division of Urology, European Institute of Oncology-IRCCS, 20132 Milan, Italy.
  • Facchini G; Urology Clinic, Monaldi Hospital, 80125 Naples, Italy.
  • Persani L; Urology Unit, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Schmitt K; UOC of Medical Oncology, ASL NA 2 Nord, "S.M. delle Grazie" Hospital, 80078 Pozzuoli, Italy.
  • Saar M; Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, 20133 Milan, Italy.
  • Stöckle M; Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano (IRCCS), 20095 Milan, Italy.
  • Unteregger G; Department of Pathology, Saarland University Medical Center, 66421 Homburg, Germany.
  • Zappavigna S; Clinic of Urology and Pediatric Urology, University of Saarland, 66421 Homburg, Germany.
Cancers (Basel) ; 14(12)2022 Jun 14.
Article em En | MEDLINE | ID: mdl-35740605
ABSTRACT

BACKGROUND:

Stromal components surrounding epithelial cancer cells seem to play a pivotal role during epithelial-to-mesenchymal transition (EMT), tumor invasion, and metastases. To identify the molecular mechanisms underlying tumor-stroma interactions may yield novel therapeutic targets for prostate cancer.

METHODS:

Gene expression profile of prostate-cancer associated fibroblast (PCAF) and prostate non-cancer associated fibroblast (PNAF) cells isolated from radical prostatectomy was performed by Illumina, analyzed, and further processed by Ingenuity® IPA® software. qRT-PCR was performed on an independent set of 17 PCAF, 12 PNAF, and 12 fibroblast cell lines derived from patients with benign prostatic hyperplasia (BPHF).

RESULTS:

Using microarray analysis, we found six upregulated genes and two downregulated genes in PCAFs compared to PNAFs. To validate microarray results, we performed qRT-PCR for the most significantly regulated genes involved in the modulation of proliferation and androgen resistance on an independent set of PNAF, PCAF, and BHPF samples. We confirmed the increased expression of SCARB1, MAPK3K1, and TGF-ß as well as the decreased expression of S100A10 in PCAFs compared to PNAFs and BPHFs.

CONCLUSIONS:

These results provide strong evidence that the observed changes in the gene expression profile of PCAFs can contribute to functional alteration of adjacent prostate cancer cells.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article